APA (7th ed.) Citation

KA, M., ML, G., DT, A., JL, L., MJ, H., KJ, T., . . . PS, D. (2026). Alpha-Particle Therapy with an Actinium-225 Labeled Bivalent Inhibitor of Prostate-Specific Membrane Antigen is Therapeutically Efficacious in a Mouse Model of Prostate Cancer. Journal of medicinal chemistry, 69(14), 17462. https://doi.org/10.1021/acs.jmedchem.6c01378

Chicago Style (17th ed.) Citation

KA, Morgan, Grieve ML, Akhter DT, Lange JL, Harris MJ, Thurecht KJ, Paterson BM, and Donnelly PS. "Alpha-Particle Therapy with an Actinium-225 Labeled Bivalent Inhibitor of Prostate-Specific Membrane Antigen Is Therapeutically Efficacious in a Mouse Model of Prostate Cancer." Journal of Medicinal Chemistry 69, no. 14 (2026): 17462. https://doi.org/10.1021/acs.jmedchem.6c01378.

MLA (9th ed.) Citation

KA, Morgan, et al. "Alpha-Particle Therapy with an Actinium-225 Labeled Bivalent Inhibitor of Prostate-Specific Membrane Antigen Is Therapeutically Efficacious in a Mouse Model of Prostate Cancer." Journal of Medicinal Chemistry, vol. 69, no. 14, 2026, p. 17462, https://doi.org/10.1021/acs.jmedchem.6c01378.